Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methodologic problems in clinical trials in heart failure.

G H Guyatt

    Journal of Chronic Diseases
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Abstracts of presentations to the Annual Meetings of the Canadian Society of Colon and Rectal Surgeons Canadian Association of General Surgeons Canadian Association of Thoracic Surgeons: Canadian Surgery Forum, Toronto, Ont., September 6-9, 2007.

    Canadian journal of surgery. Journal canadien de chirurgie·2023
    Same author

    Reconciling contrasting guideline recommendations on red and processed meat for health outcomes.

    Journal of clinical epidemiology·2021
    Same author

    A systematic survey of randomised trials that stopped early for reasons of futility.

    BMC medical research methodology·2020
    Same author

    Randomised trials with provision for early stopping for benefit (or harm): The impact on the estimated treatment effect.

    Statistics in medicine·2019
    Same author

    Low-intensity pulsed ultrasound for treatment of tibial fractures: an economic evaluation of the TRUST study.

    The bone & joint journal·2017
    Same author

    RE: Which estimates comprise optimal reporting in systematic reviews?

    Journal of clinical epidemiology·2017
    Same journal

    LEPROMATOUS LEPROSY AND AUSTRALIA ANTIGEN WITH COMMENTS ON THE GENETICS OF LEPROSY.

    Journal of chronic diseases·2015
    Same journal

    HYPERLIPIDEMIA IN AN ADULT DIABETIC POPULATION.

    Journal of chronic diseases·2015
    Same journal

    ESSENTIAL TRACE METALS IN MAN: MOLYBDENUM.

    Journal of chronic diseases·2015
    Same journal

    DISTINGUISHING PHYSIOLOGIC VARIATION FROM ANALYTIC VARIATION.

    Journal of chronic diseases·2015
    Same journal

    THE PRE-THERAPEUTIC CLASSIFICATION OF CO-MORBIDITY IN CHRONIC DISEASE.

    Journal of chronic diseases·2015
    Same journal

    AORTITIS SYNDROME WITH SPECIAL REFERENCE TO ITS CLINICAL PICTURE AND ETIOLOGY.

    Journal of chronic diseases·2015
    See all related articles

    Designing effective pharmacologic therapy trials for chronic heart failure requires careful consideration of methodological challenges. Long-term patient benefit may necessitate quality of life measures over mortality, given early improvements don't predict sustained outcomes.

    Area of Science:

    • Clinical Pharmacology
    • Cardiology
    • Medical Research Methodology

    Background:

    • Intervention trials in chronic diseases, such as chronic heart failure, present unique methodological challenges.
    • Early improvements in hemodynamic status or exercise capacity do not reliably predict long-term outcomes in these conditions.

    Purpose of the Study:

    • To highlight critical methodological issues in designing and conducting intervention trials for chronic diseases.
    • To emphasize the need for appropriate outcome measures and subject selection in chronic disease research.

    Main Methods:

    • The abstract discusses challenges related to outcome assessment, including the limitations of hemodynamic variables and exercise capacity as predictors of long-term change.
    • It addresses strategies for managing cointerventions and the potential benefits and risks of cross-over designs.

    Related Experiment Videos

    Main Results:

    • Hemodynamic status and exercise capacity improvements do not correlate with each other or predict long-term changes.
    • Mortality may not be a feasible primary outcome; quality of life measures are suggested as necessary for assessing patient benefit.

    Conclusions:

    • Methodological issues in chronic disease intervention trials necessitate careful planning regarding outcome measures, subject representativeness, and study design.
    • Considering quality of life as an outcome and employing robust strategies for cointervention management are crucial for valid trial results.